Dermatologists' Educational Demonstration for Epiduo Application
NCT ID: NCT02192632
Last Updated: 2015-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
85 participants
INTERVENTIONAL
2014-01-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DUAC® Early Onset Efficacy Study in Japanese Subjects
NCT02557399
Effect of Samples on Acne Treatment With Epiduo® Gel
NCT01504204
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris
NCT00757523
Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029
NCT01938482
Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products
NCT02731105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epiduo- dermatologist's detailed instruction
After randomly assigned to side of epiduo application, half of total patients were also re-assigned into detailed instruction for application of epiduo from dermatologist
Epiduo once daily with detailed instruction for how to apply it
Epiduo- drug insert only gruop
After randomly assigned to side of epiduo application, half of total patients were also re-assigned into drug insert only group
Epiduo- once daily, simple instruction for application
BPO group
After randomly assigned to side of BPO application, patients apply BPO during 12 week
BPO once daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epiduo once daily with detailed instruction for how to apply it
Epiduo- once daily, simple instruction for application
BPO once daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age: 18-40
Exclusion Criteria
* mental illness
* intake of oral isotretinoin within 6 months
* application of the other oral or topical acne medications
* chemical peeling or light based treatments within 6 weeks.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dae Hun Suh
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatology, Seoul National University
Seoul, Joungro, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1402-051-555
Identifier Type: REGISTRY
Identifier Source: secondary_id
ADP-BPO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.